Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SRZN · against 341 other Healthcare companies of similar size
Ranked #293 of 342 · scores higher than 13% of peers
Bars: peers in each 10-point band of the growth score50 peers with a growth score of 0–9, including SRZN · Click a bar to see the companies
Mainly because of its 3-year revenue growth, earnings per share growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | SRZN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 356 reported | -8.8% | 2.6% | 25% | 33% | |
| Earnings per share growthHigher is better · 167 reported | Not reported | 2.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 334 reported | -34.7% | 3.7% | 4% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 2 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 609M USD | 99 | 91 | |
| 293 | 4.3B CNY (≈$608M) | 9 | 20 | |
| 293 | 1.8B CNY (≈$255M) | 9 | 29 | |
| 293 | 2.3B CNY (≈$318M) | 9 | 44 | |
| 293 | 2.5B CNY (≈$355M) | 9 | 24 | |
| 293 | 354M USD | 9 | 13 | |
| 299 | 2.5B CNY (≈$349M) | 8 | 27 | |
| 299 | 1.9B CNY (≈$262M) | 8 | 24 | |
| 299 | 8.1B TWD (≈$251M) | 8 | 69 | |
| 299 | 205M USD | 8 | 36 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score